PROPHYLAXIS WITH OKT3 FOR LIVER-TRANSPLANTATION

被引：0
|
作者：
MUHLBACHER, F [1 ]
STEININGER, R [1 ]
LANGLE, F [1 ]
HAMILTON, G [1 ]
SAUTNER, T [1 ]
GNANT, M [1 ]
GOTZINGER, P [1 ]
PIZA, F [1 ]
POPOW, T [1 ]
机构：
[1] UNIV VIENNA,INST VIROL,A-1010 VIENNA,AUSTRIA
来源：
TRANSPLANTATION PROCEEDINGS | 1989年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：25 / 30
页数：6
相关论文
共 50 条
  • [21] Efficacy of rejection prophylaxis with OKT3 in renal transplantation
    Opelz, G
    TRANSPLANTATION, 1995, 60 (11) : 1220 - 1224
  • [22] OKT3 PROPHYLAXIS IN LIVER-TRANSPLANT PATIENTS
    MCDIARMID, SV
    LEWIN, KJ
    BUSUTTIL, RW
    TRANSPLANTATION, 1990, 49 (06) : 1203 - 1204
  • [23] Basiliximab and OKT3 in liver transplantation.
    Elkhammas, EA
    Carmona, MM
    Henry, ML
    Bumgardner, GL
    Pelletier, RP
    Ferguson, RM
    HEPATOLOGY, 1999, 30 (04) : 175A - 175A
  • [24] MOUSE ANTIBODY-COATED LYMPHOCYTES DURING OKT3 THERAPY IN LIVER-TRANSPLANTATION
    BROUGHAN, TA
    VALENZUELA, R
    ESCORCIA, E
    SECIC, M
    VOGT, DP
    CLINICAL TRANSPLANTATION, 1994, 8 (05) : 488 - 491
  • [25] ALG VERSUS OKT3 PROPHYLAXIS IN KIDNEY-TRANSPLANTATION
    OSUNA, A
    OSORIO, JM
    BIECHY, M
    PALOMARES, M
    BRAVO, J
    RUBERT, A
    ASENSIO, C
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 583 - 583
  • [26] USE OF OKT3 AS PROPHYLAXIS IN CADAVERIC RENAL-TRANSPLANTATION
    SHIELD, CF
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (06) : 15 - 18
  • [27] PROPHYLACTIC ATG OR OKT3 IN LIVER-TRANSPLANTATION IN THE PRESENCE OF CONTRAINDICATIONS TO CYCLOSPORINE (CYA) OR AZATHIOPRINE (AZA)
    GUGENHEIM, J
    SAMUEL, D
    CHALAND, P
    SALIBA, F
    BISMUTH, H
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2257 - 2257
  • [28] OKT3 TREATMENT FOR ALLOGRAFT-REJECTION IS A RISK FACTOR FOR CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANTATION
    PORTELA, D
    PATEL, R
    LARSONKELLER, JJ
    ILSTRUP, DM
    WIESNER, RH
    STEERS, JL
    KROM, RAF
    PAYA, CV
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 1014 - 1018
  • [29] USE OF OKT3 MONOCLONAL-ANTIBODY AS INDUCTION THERAPY FOR CONTROL OF REJECTION IN LIVER-TRANSPLANTATION
    WALL, WJ
    GHENT, CN
    ROY, A
    MCALISTER, VC
    GRANT, DR
    ADAMS, PC
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (01) : 52 - 57
  • [30] Basiliximab vs OKT3 in liver transplantation.
    Elkhalammas, EA
    Henry, ML
    Demirag, A
    Carmona, MM
    Bumgardner, GL
    Pelletier, RP
    Feguson, RM
    TRANSPLANTATION, 2000, 69 (08) : S167 - S167
12345